A Controlled Study Evaluating Relative Benefits of Two Types of Review after an A&E Attendance

ISRCTN ISRCTN11122844
DOI https://doi.org/10.1186/ISRCTN11122844
Protocol serial number AM1/06/004
Sponsor Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Funder NHS Asthma National Research and Development Programme (UK)
Submission date
23/01/2004
Registration date
23/01/2004
Last edited
15/12/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Liesl Osman
Scientific

Chest Clinic (Clinic C)
University of Aberdeen
Aberdeen Royal Infirmary
Foresterhill
Aberdeen
AB25 2ZN
United Kingdom

Phone +44 (0)1224 681 818 extn 51223
Email l.osman@abdn.ac.uk

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific title
Study objectivesThe study will compare relative benefits of the two interventions for cost effectiveness, reduction in the use of emergency services and improving patient outcomes. The study offers potential benefits to patients in improved services and reduced morbidity and to the NHS in improved efficiency and reduction of costs for emergency care. It will increase our understanding of why patients use A&E in preference to general practice care.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedRespiratory tract diseases: Asthma
Intervention1. Specialist follow-up after A&E attendance vs. no follow-up
2. Telephone follow-up with mailed asthma information vs. no telephone follow up
Intervention typeOther
Primary outcome measure(s)

Re-attendance at Accident and Emergency and hospital admission, patient attendance at GP follow up, asthma medication prescriptions over the next 12 months, patient self management, morbidity and QOL at 1 month, 6 months and 12 months. A cost benefit analysis will be carried out.

Key secondary outcome measure(s)

Not provided at time of registration

Completion date31/05/2001

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target sample size at registration300
Key inclusion criteria300 patients attending A&E due to asthma will be entered into the study over 15 months and outcomes assessed for 12 months after entry.
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/10/1997
Date of final enrolment31/05/2001

Locations

Countries of recruitment

  • United Kingdom
  • Scotland

Study participating centre

Chest Clinic (Clinic C)
Aberdeen
AB25 2ZN
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/10/2002 Yes No